5th February 2019
Medicinal cannabis is now legal in the UK, though many barriers remain to its implementation. The DrugScience Symposium discussed paths forward to facilitate patient access and data collection for scientific research.
18th August 2018
In response to rising concern over 'monkey dust', David Nutt calls for expanded drug safety testing and a frank discussion on the roles of the UK's classification system compared to drug harms
6th May 2018
A chapter by David Nutt aimed at sixth formers discussing the mechanisms and treatment options for a wide range of drug addictions and dependencies
2nd August 2017
Fentanyl has made landfall in the UK and deaths are rapidly occuring. What can be done to prevent a US-size opioid crisis?
24th January 2017
The ACMD has voted to keep THCv, a non-psychoactive cannabinoid with a promising properties for a range of health conditions, in Schedule 1 away from the hands of researchers.
4th January 2017
In an effort to curb the current wave of recreational synthetic cannabinoids, the Government have introduced new controls for a range of core chemical structures. These structures are also found in many pharmaceuticals and could stifle future pharmaceutical development
22nd December 2016
The WHO has commissioned a cannabis review before the Commission for Narcotic Drugs 2018 meeting. This will be first WHO cannabis review since 1935!
1st December 2016
Two landmark studies have been published, showing a single psychedelic experience could produce profound and enduring mental health benefits. What does the future of psychedelic therapy hold?
13th September 2016
The recent deaths at Fabric were tragic, and more will follow them if we do not embrace receational drug harm reduction measures.
21st March 2016
18th February 2015
14th March 2014
31st January 2014
6th November 2013
3rd July 2013
28th April 2011